U.S. RESEARCH ROUNDUP- Amgen, Firstcash, Nike

Firstcash Holdings

21/12/2021 07:26

Dec 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Amgen, Firstcash and Nike, on Tuesday. 
    
  HIGHLIGHTS        
     * Amgen Inc  AMGN.O : RBC raises target price to $218 from $216
     * Cerner Corp  CERN.O : Canaccord Genuity cuts to hold from buy
     * Firstcash Inc  FCFS.O : Jefferies resumes coverage with buy rating and $105 target price
     * Nike Inc  NKE.N : Piper Sandler raises target price to $183 from $174
     * Vir Biotechnology Inc  VIR.O : Baird cuts to underperform rating
                
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.    
     * 1Life Healthcare Inc  ONEM.O : JP Morgan cuts target price to $28 from $41
     * Acadia Pharmaceuticals Inc  ACAD.O : Citigroup raises price target to $30 from $28
     * Acadia Pharmaceuticals Inc  ACAD.O : Cowen and Company raises PT to $32 from $30
     * Acadia Pharmaceuticals Inc  ACAD.O : Jefferies raises target price to $28 from $21
     * Acadia Pharmaceuticals Inc  ACAD.O : RBC raises target price to $34 from $32
     * Akumin Inc  AKU.O : Canaccord Genuity cuts target price to $3.50 from $5
     * Aldeyra Therapeutics Inc  ALDX.O : Jefferies cuts target price to $16 from $24
     * Aldeyra Therapeutics Inc  ALDX.O : SVB Leerink cuts target price to $15 from $24
     * Amgen Inc  AMGN.O : RBC raises target price to $218 from $216
     * Aptose Biosciences Inc  APTO.O : H.C. Wainwright cuts target price to $12 from $14
     * Biogen Inc  BIIB.O : JP Morgan cuts target price to $276 from $324
     * Biogen Inc  BIIB.O : Piper Sandler cuts target price to $362 from $388
     * Bluerock Residential Growth REIT  BRG.A : Colliers Securities ups PT to $29.85 from $14
     * Carnival Corp  CCL.N : Credit Suisse cuts target price to $38 from $41
     * Cerner Corp  CERN.O : Canaccord Genuity cuts to hold from buy
     * Cerner Corp  CERN.O : Canaccord Genuity raises target price to $95 from $90
     * Cerner Corp  CERN.O : JP Morgan raises target price to $95 from $83
     * Cerner Corp  CERN.O : RBC cuts to sector perform from outperform
     * Cerner Corp  CERN.O : RBC raises target price to $95 from $86
     * Cerner Corp  CERN.O : SVB Leerink cuts to market perform from outperform
     * Cerner Corp  CERN.O : SVB Leerink raises target price to $95 from $88
     * Cigna Corp  CI.N : JP Morgan cuts to neutral from overweight
     * Cigna Corp  CI.N : JP Morgan cuts target price to $248 from $270
     * Cytomx Therapeutics Inc  CTMX.O : Jefferies cuts target price to $12 from $14
     * Darden Restaurants Inc  DRI.N : Stephens cuts target price to $170 from $180
     * Eldorado Gold Corp  EGO.N : CIBC cuts target price to $15 from $16
     * Firstcash Inc  FCFS.O : Jefferies resumes coverage with buy rating and $105 target price
     * Global Blood Therapeutics Inc  GBT.O : SVB Leerink cuts target price to $53 from $56
     * HCA Healthcare Inc  HCA.N : JP Morgan cuts to neutral from overweight
     * Immunitybio Inc  IBRX.O : Piper Sandler cuts target price to $20 from $25
     * Intra-Cellular Therapies Inc  ITCI.O : Canaccord Genuity raises target price to $88 from $81
     * Intra-Cellular Therapies Inc  ITCI.O : RBC raises target price to $55 from $50
     * iRhythm Technologies  IRTC.O : Canaccord Genuity reinstates with buy rating; PT $125
     * Lennar Corp  LEN.N : Raymond James raises target price to $125 from $120
     * Micron Technology Inc  MU.O : Cowen and Company raises target price to $101 from $99
     * Micron Technology Inc  MU.O : Credit Suisse raises target price to $130 from $110
     * Nike Inc  NKE.N : Cowen and Company raises target price to $192 from $189
     * Nike Inc  NKE.N : Piper Sandler raises target price to $183 from $174
     * Novavax Inc  NVAX.O : JP Morgan raises target price to $209 from $172
     * RingCentral Inc  RNG.N : Evercore ISI cuts target price to $275 from $410
     * Sociedad Quimica Y Minera De Chile SA  SQM.N : Scotiabank cuts to sector underperform from
 sector perform
     * Sociedad Quimica Y Minera De Chile SA  SQM.N : Scotiabank cuts target to $47 from $59
     * Southside Bancshares Inc  SBSI.O : Stephens initiates with equal-weight rating and $45 PT
     * Taskus Inc  TASK.O : BTIG cuts target price to $70 from $75
     * Vir Biotechnology Inc  VIR.O : Baird cuts to underperform rating
    

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))